Related Experiment Video
Updated: Mar 21, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS),
E H Teshale1, J Xing2, A Moorman2
1Division of Viral Hepatitis, CDC, Atlanta, GA, USA. eht4@cdc.gov.
Insights
Patients with chronic hepatitis C virus (HCV) infection experience significantly higher hospitalization rates, nearly 3.7 times greater than the general population. This underscores the substantial healthcare burden and costs associated with HCV.
Area of Science:
- Hepatology
- Public Health
- Health Economics
Background:
- Chronic hepatitis C virus (HCV) infection leads to high hospitalization rates in the U.S.
- The full healthcare burden of HCV-related hospitalizations remains unclear.
Purpose of the Study:
- To determine and compare all-cause hospitalization rates between patients with chronic HCV infection and matched health system patients.
- To identify the primary reasons for hospitalization in chronic HCV patients versus the general population.
Main Methods:
- Analysis of data from the Chronic Hepatitis Cohort Study (2006-2013).
- Propensity score matching (PSM) used to compare 10,131 chronic HCV patients with 20,262 health system patients.
- PSM accounted for site, gender, race, age, and household income.
Main Results:
- All-cause hospitalization rates were 27.4 per 100 person-years (PY) for HCV patients vs. 7.4 per 100 PY for controls.
- HCV patients had a 3.7-fold higher all-cause hospitalization rate.
- HCV patients were significantly more likely to be hospitalized for liver-related conditions (RR = 24.8).
Conclusions:
- Patients with chronic HCV infection face substantially higher hospitalization rates and associated healthcare burdens.
- Findings highlight the significant economic and clinical impact of chronic HCV infection.
- Effective HCV management is crucial to reduce hospitalization and healthcare costs.
Abstract:
In the United States, hospitalization among patients with chronic hepatitis C virus (HCV) infection is high. The healthcare burden associated with hospitalization is not clearly known. We analysed data from the Chronic Hepatitis Cohort Study, an observational cohort of patients receiving care at four integrated healthcare systems, collected from 2006 to 2013 to determine all-cause hospitalization rates of patients with chronic HCV infection and the other health system patients. To compare the hospitalization rates, we selected two health system patients for each chronic HCV patient using their propensity score (PS). Propensity score matching was conducted by site, gender, race, age and household income to minimize differences attributable to these characteristics. We also compared primary reason for hospitalization between chronic HCV patients and the other health system patients. Overall, 10 131 patients with chronic HCV infection and 20 262 health system patients were selected from the 1 867 802 health system patients and were matched by PS. All-cause hospitalization rates were 27.4 (27.0-27.8) and 7.4 (7.2-7.5) per 100 persons-year (PY) for chronic HCV patients and for the other health system patients, respectively. Compared to health system patients, hospitalization rates were significantly higher by site, gender, age group, race and household income among chronic HCV patients (P < 0.001). Compared to health system patients, chronic HCV patients were more likely to be hospitalized from liver-related conditions (RR = 24.8, P < 0.001). Hence, patients with chronic HCV infection had approximately 3.7-fold higher all-cause hospitalization rate than other health system patients. These findings highlight the incremental costs and healthcare burden of patients with chronic HCV infection associated with hospitalization.
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

